End-point tumours (having reached 150 mm2) from mice vaccinated with either control VP60 VLP or surv.VLP-SS-MUC1 were excised and analysed by flow cytometry to examine the expression of T-cell exhausted markers (n = 5) or analysed by immunohistochemistry (IHC) for CD3+ to examine T-cell infiltration (n = 5). This evidence concerns the gene MUC1 and neoplasm.